News
Press Releases
- 02.09.2010
Xencor Appoints Edgardo Baracchini, Ph.D., to Chief Business Officer - 01.19.2010
Data Published in Nature Biotechnology Shows Fc Engineering Improves Antibody Efficacy and Convenience - 12.16.2009
Xencor Receives Milestone Payment from Pfizer Under Antibody Technology License Agreement - 12.07.2009
Xencor Appoints Former ZymoGenetics CEO, Bruce Carter, to Chairman of the Board - 11.30.2009
Xencor Licenses Antibody Optimization Technology - 06.29.2009
Xencor Appoints Jeffrey V. Ravetch of The Rockefeller University to its Scientific Advisory Board - 06.01.2009
Xencor Presents Preliminary Phase 1 Data on XmAb®2513 Antibody for Lymphomas at 2009 American Society of Clinical Oncology Annual Meeting - 05.15.2009
Xencor to Present Phase 1 Data on XmAb®2513 Antibody for Lymphomas at the American Society of Clinical Oncology Annual Meeting - 03.23.2009
Xencor Licenses Xtend Antibody Half-life Prolongation Platform to Merck & Co., Inc. - 03.02.2009
Xencor and Pfizer enter into Antibody Technology Licensing Agreement - 02.23.2009
Xencor and CSL Limited Establish Antibody Optimization Collaboration - 12.09.2008
Xencor Presents Data from Pre-clinical Studies of its Anti-CD19 and Anti-CD40 Antibodies at the 50th Annual Meeting of the American Society of Hematology - 12.02.2008
Xencor to Present New Data from Pre-Clinical Antibody Programs at Upcoming ASH Conference - 06.01.2008
Xencor to Present New Data from Anti-CD19 Antibody Program at ASCO - 04.15.2008
Xencor Presents Pre-Clinical Data for Anti-CD19 Antibody at AACR - 04.09.2008
Xencor to Present New Data from CD19 Program at Upcoming Scientific Meetings - 03.19.2008
Xencor Appoints Industry Veteran David R. King as Chairman of its Board of Directors - 02.11.2008
Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma - 02.07.2008
Human Genome Sciences And Xencor Announce Antibody Collaboration - 01.09.2008
Xencor Receives Patent for its Proprietary Antibody Fc Optimization Technology - 12.10.2007
Xencor Data from Pre-clinical XmAb Antibody Studies Presented at American Society of Hematology Meeting - 12.07.2007
Xencor Presents Findings on New Aspect of its Fc Technology Targeting Autoimmune Disease - 10.24.2007
Jeffrey D. Bloss, M.D., Joins Xencor as Chief Medical Officer - 10.24.2007
Xencor Expands Series E Financing to $60 Million - 09.20.2007
Xencor Selects Antibody Development Candidates - 07.23.2007
Xencor Data Published in Journal of Immunology Demonstrate Selectivity of New Class of Inhibitors for Inflammatory Disease - 02.13.2007
Boehringer Ingelheim and Xencor Enter into Antibody License and Commercialization Agreement - 10.19.2006
Xencor Completes $45 Million Financing with MedImmune Ventures, Novo Nordisk and HealthCare Ventures - 09.11.2006
Xencors XmAb Technology Wins Wall Street Journal 2006 Technology Innovation Award - 07.11.2006
Xencor Completes $6 Million Bridge Financing with Novo Nordisk and Existing Investors - 03.07.2006
Data Published in PNAS Show Engineering the Fc Region of Antibodies Makes Them More Toxic to Cancer Cells - 02.14.2006
Xencor Licenses Immunofilter Technology to Centocor Research and Development, Inc. - 01.18.2006
Lilly Licenses Xencor's Immunofilter Technology - 01.04.2006
Xencor and Roche Extend XmAb Antibody Therapeutics Collaboration - 12.07.2005
MedImmune Licenses Xencor's XmAb Technology To Create Antibody Therapeutics Against Select Tumor Targets; Fifth XmAb Deal For Xencor In The Last Year - 10.18.2005
Xencor Gives Panel Presentation and Company Update at BIO InvestorForum; Announces Recent Close of $20 Million in Financing - 07.18.2005
Xencor, Inc. Signs Collaboration with Centocor, Inc. to Improve Antibodies - 06.21.2005
FierceBiotech Honors Xencor as One of the - 04.13.2005
Xencor Licenses Protein Variants to Lilly - 01.10.2005
Xencor and Chugai Initiate Partnership for Optimized Antibodies - 12.01.2004
Xencor and Genentech to Collaborate to Develop Next-Generation Antibody Therapeutics - 02.18.2004
Xencor Announces Protein Optimization Collaboration with Lilly - 01.28.2004
Xencor Determines Structure Of Baff, A Key Autoimmune Disease Target - 01.12.2004
Xencor and Protein Design Labs Initiate Partnership for Optimized Antibodies - 12.09.2003
Xencor Announces Bassil Dahiyat As Its New Chief Scientific Officer - 12.09.2003
Xencor Announces Harry Stylli As Its New Chief Executive Officer - 09.25.2003
Xencor Designs Novel TNF Alpha Inhibitors To Treat Inflammatory Disease - 09.24.2003
Xencor Granted Patent on Optimized Pharmaceutical Protein - 09.23.2003
Chromos and Xencor announce agreement for use of the ACE System to produce biologics. - 09.23.2003
Bassil Dahiyat Named One of the World's Top Young Innovators - 10.09.2002
Xencor Receives Advanced Technology Program Grant For Safer Protein Therapeutics - 06.17.2002
Xencor Reaches Research Milestone - 06.04.2002
Enhancing The Therapeutic Utility of Biopharmaceuticals: The Next Frontier - 05.29.2002
Xencor Optimizes Key Pharmaceutical Proteins - 04.18.2002
Chemical Genomics - CALBIOsummit 2002 April 21,22,23 - 03.11.2002
Xencor Licenses Patent For Chemical Genomics Technology Profiling Biological And Pharmacological Interactions - 02.20.2002
Xencor Expands Protein Optimization Technology To Develop Next-Generation Biotechnology Products - 01.03.2002
Syngenta's Torrey Mesa Research Institute And Xencor Sign Research And License Agreement - 10.09.2001
Xencor Expands Management Team To Lead Drug Discovery And Protein Optimization Programs - 08.06.2001
Xencor Receives Two Patents For Ultra-Fast Optimization Technology To Create A New Generation Of Biotechnology Products - 07.19.2001
Xencor Expands Management Team; Leverages $50 Million Series C Financing to Fuel Development Efforts - 06.19.2001
Xencor Receives SBIR Phase II Grant for High Throughput Screening of Novel Computationally Derived Optimized Proteins - 11.01.2000
Xencor Closes $50 Million Series C Financing - 06.14.1999
Xencor Closes $12.3 Million in Financing - 01.05.1999
Xencor Co-Founder, Stephen Mayo, Presents Protein Design Automation Results at AAAS Meeting - 11.30.1998
Xencor Licenses Caltech Technology
Copyright © 2005 Xencor, Inc. All rights reserved. Designed by